These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7809837)

  • 1. Effects of the antihypercalcemic drugs gallium nitrate and pamidronate on hormone release of pathologic human parathyroid cells.
    Ridefelt P; Gylfe E; Akerström G; Rastad J
    Surgery; 1995 Jan; 117(1):56-61. PubMed ID: 7809837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid tissue in normocalcemic and hypercalcemic primary hyperparathyroidism recruited by health screening.
    Lundgren E; Ridefelt P; Akerström G; Ljunghall S; Rastad J
    World J Surg; 1996 Sep; 20(7):727-34; discussion 735. PubMed ID: 8678973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ga3+ inhibits parathyroid hormone release without interacting with the Ca2+ receptor of the parathyroid cell.
    Ridefelt P; Hellman P; Ljunggren O; Ljunghall S; Akerström G; Rastad J; Gylfe E
    Biochem Biophys Res Commun; 1992 Jul; 186(1):556-61. PubMed ID: 1321615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical effects of K+ and D-600 on parathyroid hormone secretion and cytoplasmic Ca2+ in normal bovine and pathological human parathyroid cells.
    Larsson R; Akerström G; Gylfe E; Johansson H; Ljunghall S; Rastad J; Wallfelt C
    Biochim Biophys Acta; 1985 Nov; 847(2):263-9. PubMed ID: 4063399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism.
    Wallfelt C; Gylfe E; Larsson R; Ljunghall S; Rastad J; Akerström G
    J Endocrinol; 1988 Mar; 116(3):457-64. PubMed ID: 3351432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual effects of a new hypocalcemic agent, WR-2721, on cytoplasmic Ca2+ and parathyroid hormone release of dispersed parathyroid cells from patients with hyperparathyroidism.
    Larsson R; Nygren P; Wallfelt C; Akerström G; Rastad J; Ljunghall S; Gylfe E
    Biochem Pharmacol; 1986 Dec; 35(23):4237-41. PubMed ID: 3024645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
    Lu KC; Yeung LK; Lin SH; Lin YF; Chu P
    Am J Kidney Dis; 2003 Dec; 42(6):1221-7. PubMed ID: 14655194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective regulation of the cytosolic Ca2+ activity in parathyroid cells from patients with hyperparathyroidism.
    Larsson R; Wallfelt C; Abrahamsson H; Gylfe E; Ljunghall S; Rastad J; Rorsman P; Wide L; Akerström G
    Biosci Rep; 1984 Nov; 4(11):909-15. PubMed ID: 6525449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
    Malberti F; Farina M; Imbasciati E
    Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalizing effect of Ca2+ ionophore on cytoplasmic Ca2+ and parathyroid hormone release of dispersed parathyroid cells from patients with hyperparathyroidism.
    Larsson R; Wallfelt C; Akerström G; Ljunghall S; Rastad J; Gylfe E
    Mol Cell Endocrinol; 1986 May; 45(2-3):191-6. PubMed ID: 3086157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl sulfoxide increases cytoplasmic Ca2+ concentration and inhibits parathyroid hormone release in normal bovine and pathological human parathyroid cells.
    Nygren P; Larsson R; Rastad J; Akerström G; Gylfe E
    Biochim Biophys Acta; 1987 Apr; 928(2):194-8. PubMed ID: 3567228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-autonomy of parathyroid hormone secretion in acute primary hyperparathyroidism.
    Schachter PP; Christy MD; Avigad IS; Shabtay M; Leight GS
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):565-9. PubMed ID: 1286527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of parathyroid hormone release in normal and pathological parathyroid cells exposed to modulators of protein kinase C.
    Ridefelt P; Nygren P; Hellman P; Larsson R; Rastad J; Akerström G; Gylfe E
    Acta Endocrinol (Copenh); 1992 Jun; 126(6):505-9. PubMed ID: 1642085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of parathyroid hormone secretion during correction of tumor-associated hypercalcemia.
    Body JJ; Dumon JC; Seraj F; Cleeren A
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1385-8. PubMed ID: 1592885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S; Tisell LE; Lindstedt G; Lundberg PA
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies.
    Juhlin C; Klareskog L; Nygren P; Ljunghall S; Gylfe E; Rastad J; Akerström G
    Endocrinology; 1988 Jun; 122(6):2999-3001. PubMed ID: 2836180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive escape from parathyroid suppression: a common phenomenon in primary hyperparathyroidism (a calcium clamp study).
    Sørensen HA; Schwarz P; Hyldstrup L; Transbøl I
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):309-15. PubMed ID: 8187293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma.
    Warrell RP; Issacs M; Alcock NW; Bockman RS
    Ann Intern Med; 1987 Nov; 107(5):683-6. PubMed ID: 2821862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pamidronate corrects the down-regulation of the renal parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor mRNA in rats bearing Walker tumors.
    Yaghoobian J; Morieux C; Denne MA; Bouizar Z; Ureña P; de Vernejoul MC
    Horm Metab Res; 1998 May; 30(5):249-55. PubMed ID: 9660083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.